These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 32697344)

  • 1. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.
    Mahalaxmi I; Kaavya J; Mohana Devi S; Balachandar V
    J Cell Physiol; 2021 Feb; 236(2):763-770. PubMed ID: 32697344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-viral effects of COVID-19 in the olfactory system and their implications.
    Xydakis MS; Albers MW; Holbrook EH; Lyon DM; Shih RY; Frasnelli JA; Pagenstecher A; Kupke A; Enquist LW; Perlman S
    Lancet Neurol; 2021 Sep; 20(9):753-761. PubMed ID: 34339626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Dysfunction in the COVID-19 Outbreak.
    Izquierdo-Dominguez A; Rojas-Lechuga MJ; Mullol J; Alobid I
    J Investig Allergol Clin Immunol; 2020; 30(5):317-326. PubMed ID: 32406374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential convergence of olfactory dysfunction in Parkinson's disease and COVID-19: The role of neuroinflammation.
    Li H; Qian J; Wang Y; Wang J; Mi X; Qu L; Song N; Xie J
    Ageing Res Rev; 2024 Jun; 97():102288. PubMed ID: 38580172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Molecular Basis of Olfactory Dysfunction in COVID-19 and Long COVID.
    Anastassopoulou C; Davaris N; Ferous S; Siafakas N; Boufidou F; Anagnostopoulos K; Tsakris A
    Lifestyle Genom; 2024; 17(1):42-56. PubMed ID: 38749402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19.
    Sowa P; Dadok A; Adamczyk-Sowa M
    Neurol Neurochir Pol; 2023; 57(1):36-42. PubMed ID: 36805466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
    Las Casas Lima MH; Cavalcante ALB; Leão SC
    Braz J Otorhinolaryngol; 2022; 88(5):794-802. PubMed ID: 33965353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and olfactory dysfunction: a looming wave of dementia?
    Kay LM
    J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
    ElBini Dhouib I
    Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The alleged mechanisms of olfactory disorders in the new coronavirus infection].
    Lashch NY; Yunyaev AR; Evsyukova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):7-11. PubMed ID: 36843453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection.
    Gómez-Iglesias P; Porta-Etessam J; Montalvo T; Valls-Carbó A; Gajate V; Matías-Guiu JA; Parejo-Carbonell B; González-García N; Ezpeleta D; Láinez JM; Matías-Guiu J
    Front Public Health; 2020; 8():243. PubMed ID: 32574308
    [No Abstract]   [Full Text] [Related]  

  • 13. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study.
    Ueha R; Ito T; Furukawa R; Kitabatake M; Ouji-Sageshima N; Ueha S; Koyama M; Uranaka T; Kondo K; Yamasoba T
    Front Cell Infect Microbiol; 2022; 12():924725. PubMed ID: 35770069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and anosmia: The story so far.
    Meng X; Pan Y
    Ear Nose Throat J; 2024 May; 103(5):NP312-NP320. PubMed ID: 34587819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Olfactory disorders as a multidisciplinary problem].
    Guekht AB; Kryukov AI; Kazakova AA; Akzhigitov RG; Gulyaeva NV; Druzhkova TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(12):32-38. PubMed ID: 36537628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19).
    Yazdanpanah N; Saghazadeh A; Rezaei N
    Rev Neurosci; 2020 Oct; 31(7):691-701. PubMed ID: 32776905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.